Drugs / PRO-040201
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00927459 | Jun → Dec 2009 | — | Arbutus Biopharma Corporation | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRO-040201 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00927459 ↗ |
| Modality | Small interfering RNA (siRNA) | “Liposomal siRNA” NCT00927459 ↗ |
| Route | Intravenous | “Single dose IV infusion” NCT00927459 ↗ |